DELHI HIGH COURT
PRATHIBA M.SINGH
Novartis AG – Appellant
Versus
Centurion Remedies Private Limited – Respondent
JUDGMENT
Prathiba M. Singh, J. (Oral)--This hearing has been done through hybrid mode.
2. The present suit has been filed seeking permanent injunction restraining infringement of Indian Patent No.229051, damages, rendition of accounts, delivery up etc. The details of the said patent are as under:
| Patent No. | : | IN 229051 |
| Title | : | Pharmaceutical Compositions Comprising Valsartan and NEP Inhibitors |
| Date of Filing | : | 16th January, 2003 |
| Date of Expiry | : | 16th January, 2023 |
3. Pursuant to the directions issued vide previous orders dated 20th May, 2022 and 11th May, 2022, the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers (hereinafter as `DOP') has filed an affidavit clarifying its position. As per the said affidavit, for various reasons including for enhancing supply of local manufactured products and for self-sufficiency purposes in the case of medicines, drug and medical devices, certain guidelines were issued by the Government classifying Local Suppliers based on local value addition or local content as Class I Local Supplier having local content of more than 80%, Class II Local Supplier having local content of 50-80%, and Non-Local Supplier having local content less than 5
Login now and unlock free premium legal research
Login to SupremeToday AI and access free legal analysis, AI highlights, and smart tools.
Login
now!
India’s Legal research and Law Firm App, Download now!
Copyright © 2023 Vikas Info Solution Pvt Ltd. All Rights Reserved.